Armata Pharmaceuticals, Inc. — Director's Dealing 2005

Jul 18, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-07-15

Reporting Person: BIOGEN IDEC INC (10% Owner)
Reporting Person: BIOGEN IDEC MA INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-07-15	Common Stock, $0.01 Par Value	S	33550	$0.80	Disposed	12068628	Indirect
2005-07-15	Common Stock, $0.01 Par Value	S	3000	$0.8002	Disposed	12065628	Indirect
2005-07-15	Common Stock, $0.01 Par Value	S	1750	$0.8003	Disposed	12063878	Indirect
2005-07-15	Common Stock, $0.01 Par Value	S	4000	$0.801	Disposed	12059878	Indirect
2005-07-15	Common Stock, $0.01 Par Value	S	1800	$0.81	Disposed	12058078	Indirect
2005-07-15	Common Stock, $0.01 Par Value	S	100	$0.82	Disposed	12057978	Indirect
2005-07-18	Common Stock, $0.01 Par Value	S	2500	$0.801	Disposed	12055478	Indirect
2005-07-18	Common Stock, $0.01 Par Value	S	2932	$0.81	Disposed	12052546	Indirect

Footnotes

F1: Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA Inc., fka Biogen, Inc.